Argininosuccinate Synthase 1-Deficiency Enhances the Cell Sensitivity to Arginine through Decreased DEPTOR Expression in Endometrial Cancer
Open Access
- 30 March 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep45504
Abstract
Argininosuccinate synthetase 1 (ASS1) is a rate-limiting enzyme in arginine biosynthesis. Although ASS1 expression levels are often reduced in several tumors and low ASS1 expression can be a poor prognostic factor, the underlying mechanism has not been elucidated. In this study, we reveal a novel association between ASS1 and migration/invasion of endometrial tumors via regulation of mechanistic target of rapamycin complex (mTORC) 1 signaling. ASS1-knockout cells showed enhanced migration and invasion in response to arginine following arginine starvation. In ASS1-knockout cells, DEPTOR, an inhibitor of mTORC1 signal, was downregulated and mTORC1 signaling was more activated in response to arginine. ASS1 epigenetically enhanced DEPTOR expression by altering the histone methylation. Consistent with these findings, tumor cells at the invasive front of endometrioid carcinoma cases showed lower ASS1 and DEPTOR expression. Our findings suggest that ASS1 levels in each tumor cell are associated with invasion capability in response to arginine within the tumor microenvironment through mTORC1 signal regulation.Keywords
This publication has 35 references indexed in Scilit:
- Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer CellsScience Signaling, 2014
- Glutamine and cancer: cell biology, physiology, and clinical opportunitiesJournal of Clinical Investigation, 2013
- ASS1as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic RelevanceClinical Cancer Research, 2013
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and TumorigenesisCell, 2012
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Argininosuccinate synthase: at the center of arginine metabolism2010
- Arginine Metabolism: Boundaries of Our KnowledgeThe Journal of Nutrition, 2007
- Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell culturesBritish Journal of Cancer, 2003
- Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.2002
- Arginine metabolism: nitric oxide and beyondBiochemical Journal, 1998